Niagen Bioscience (NAGE) Other financing activities (2011 - 2026)
Niagen Bioscience's (NAGE) quarterly Other financing activities came in at $111000.0 in Q1 2026, down 96.44% year-on-year from $3.1 million in Q1 2025, and down 51.32% on a QoQ basis from $228000.0 in Q4 2025.
Niagen Bioscience (NAGE) Other financing activities (2011 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 12 years of Other financing activities data on file, last reported at $111000.0 in Q1 2026.
- On a quarterly basis, Other financing activities fell 96.44% year-over-year to $111000.0 in Q1 2026; TTM through Mar 2026 was $4.2 million, a 50.35% decrease from a year earlier, with the FY2025 full-year figure at $7.2 million, up 33.39% from the prior year.
- Other financing activities for Q1 2026 stood at $111000.0, down from $228000.0 in the prior quarter.
- Over the last five years, Other financing activities for NAGE reached as high as $3.8 million in Q4 2024 and fell as low as $111000.0 in Q1 2026.
- Historically, Other financing activities has averaged $1.6 million across 3 years, with a median of $820500.0 in 2024.
- Across the five-year window, Other financing activities surged 527.42% in 2025 and tumbled 96.44% in 2026, its largest moves.
- Year by year, Other financing activities stood at $3.8 million in 2024, then slumped by 93.99% to $228000.0 in 2025, then sank by 51.32% to $111000.0 in 2026.
- Per Business Quant data, the three most recent Other financing activities figures were $111000.0 in Q1 2026, $228000.0 in Q4 2025, and $152000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Niagen Bioscience | 253.47 Mn | 186.92 Mn | 19.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 111,000.00 |
| Mar 31, 2026 | 111,000.00 |
| Dec 31, 2025 | 228,000.00 |
| Dec 31, 2025 | 228,000.00 |
| Sep 30, 2025 | 152,000.00 |
| Sep 30, 2025 | 152,000.00 |
| Jun 30, 2025 | 3.75 Mn |
| Jun 30, 2025 | 3.75 Mn |
| Mar 31, 2025 | 3.11 Mn |
| Mar 31, 2025 | 3.11 Mn |
| Dec 31, 2024 | 3.79 Mn |
| Dec 31, 2024 | 3.79 Mn |
| Sep 30, 2024 | 1.04 Mn |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 598,000.00 |
| Jun 30, 2024 | 598,000.00 |
| Dec 31, 2021 | 130,000.00 |
| Dec 31, 2021 | 130,000.00 |
| Sep 30, 2021 | 341,000.00 |
| Sep 30, 2021 | 341,000.00 |